Centre Hospitalier Universitaire d'Avicennes

Bobigny 93009

0 studies enrolling now · 3 studies all time

What they study most

Anemia, Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Leukemia, Lymphocytic, Chronic, B-Cell, Low to Intermediate-1 MDS, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Myelodysplastic Syndromes (MDS)

Studies at this site

• A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia — Completed
• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) — Completed